vimarsana.com

Page 6 - Analyst Recommendations For Exact Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Credit Suisse Group Raises Exact Sciences (NASDAQ:EXAS) Price Target to $90 00

Exact Sciences (NASDAQ:EXAS – Free Report) had its target price raised by Credit Suisse Group from $75.00 to $90.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. Credit Suisse Group currently has a neutral rating on the medical research company’s stock. Other analysts also recently issued reports about the stock. StockNews.com started […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.